{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:58:54Z","timestamp":1768643934827,"version":"3.49.0"},"reference-count":26,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"funded by Sinovac Life Sciences Co., Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2135929","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T15:33:02Z","timestamp":1669649582000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial"],"prefix":"10.1080","volume":"18","author":[{"given":"Dandan","family":"Zhu","sequence":"first","affiliation":[{"name":"Huaiyin District Center for Disease Control and Prevention, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Center, Sinovac Biotech, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuantuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Center, Sinovac Biotech, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chu","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Institution of Vaccine Clinical Trials, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Center, Sinovac Biotech, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialei","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Institution of Vaccine Clinical Trials, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Meng","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Center, Sinovac Biotech, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Tan","sequence":"additional","affiliation":[{"name":"Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingliang","family":"Wu","sequence":"additional","affiliation":[{"name":"Huaiyin District Center for Disease Control and Prevention, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Lian","sequence":"additional","affiliation":[{"name":"Sinovac Life Science, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Control of Biological Products, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Institution of Vaccine Clinical Trials, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_3_4_4_1","unstructured":"World Health Organization. COVID-19 dashboard. 2020 [accessed 2022 June 14]."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101568"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.02.021"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30154-9"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.01.022"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2606.200516"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25689"},{"key":"e_1_3_4_14_1","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape. 2021 [accessed 2022 May 05]. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02000-6"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105290"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00234-8"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04775-4"},{"key":"e_1_3_4_19_1","unstructured":"World Health Organization. COVID-19 dashboard. 2020 [accessed 2022 July 03]. https:\/\/covid19.who.int\/."},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01429-X"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.09.052"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107715"},{"key":"e_1_3_4_23_1","unstructured":"China National Medical Products Administration. Guidelines for grading standards of adverse events in clinical trials of preventive vaccines. 2019 [accessed 2022 July 03]. https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/qtggtg\/20191231111901460.html."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30843-4"},{"key":"e_1_3_4_25_1","unstructured":"SINOVAC. Inactivated COVID-19 vaccine CoronaVac has been added to the WHO\u2019s emergency use list for one year. 2020 [accessed 2022 July 14]. https:\/\/mp.weixin.qq.com\/s\/YdlwKsOlq9JezrgrYhHFBg."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.834744"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1925112"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2135929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:46:56Z","timestamp":1737049616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2135929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2135929"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2135929","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2135929"}}